blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1462149

EP1462149 - Use of phenazon for the treatment of migraine [Right-click to bookmark this link]
Former [2004/40]Medicament for the treatment of migraine based on phenazon
[2007/47]
StatusNo opposition filed within time limit
Status updated on  20.11.2009
Database last updated on 17.09.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): CY, TR
published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
Krewel Meuselbach GmbH
Krewelstrasse 2
53783 Eitorf / DE
[2004/40]
Inventor(s)01 / Schierstedt, Detlev, Dr.
Henri-Dunant-Strasse 2
53757 St. Augustin / DE
 [2009/52]
Former [2004/40]01 / Schierstedt, Dieter, Dr.
Henri-Dunant-Strasse 2
53757 St. Augustin / DE
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [2004/40]Jönsson, Hans-Peter, Dr.Dipl.-Chem., et al
Patentanwälte von Kreisler Selting Werner, Bahnhofsvorplatz 1 (Deichmannhaus am Dom)
50667 Köln / DE
Application number, filing date04006037.813.03.2004
[2004/40]
Priority number, dateDE200311344626.03.2003         Original published format: DE 10313446
[2004/40]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP1462149
Date:29.09.2004
Language:DE
[2004/40]
Type: B1 Patent specification 
No.:EP1462149
Date:07.05.2008
Language:DE
[2008/19]
Search report(s)(Supplementary) European search report - dispatched on:EP28.06.2004
ClassificationIPC:A61P29/00, A61K31/4152, A61K9/20
[2007/47]
CPC:
A61K9/2027 (EP); A61K31/4152 (EP); A61P25/06 (EP);
A61P29/00 (EP)
Former IPC [2004/40]A61P29/00, A61K31/4152, A61K9/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2004/40]
TitleGerman:Verwendung von Phenazon zur Behandlung von Migräne[2007/47]
English:Use of phenazon for the treatment of migraine[2007/47]
French:Utilisation du phenazon pour le traitement du migraine[2007/47]
Former [2004/40]Phenazon-haltiges Migränemedikament
Former [2004/40]Medicament for the treatment of migraine based on phenazon
Former [2004/40]Médicamment pour traiter migraine contenant du phenazon
Examination procedure18.01.2005Examination requested  [2005/12]
11.12.2006Despatch of a communication from the examining division (Time limit: M04)
06.03.2007Reply to a communication from the examining division
29.10.2007Communication of intention to grant the patent
26.02.2008Fee for grant paid
26.02.2008Fee for publishing/printing paid
Opposition(s)10.02.2009No opposition filed within time limit [2009/16]
Fees paidRenewal fee
30.03.2006Renewal fee patent year 03
29.03.2007Renewal fee patent year 04
18.03.2008Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY07.05.2008
DK07.05.2008
EE07.05.2008
FI07.05.2008
IE07.05.2008
NL07.05.2008
RO07.05.2008
SI07.05.2008
SK07.05.2008
TR07.05.2008
BG07.08.2008
SE07.08.2008
GR08.08.2008
ES18.08.2008
PT07.10.2008
HU08.11.2008
[2011/43]
Former [2011/32]DK07.05.2008
EE07.05.2008
FI07.05.2008
IE07.05.2008
NL07.05.2008
RO07.05.2008
SI07.05.2008
SK07.05.2008
BG07.08.2008
SE07.08.2008
GR08.08.2008
ES18.08.2008
PT07.10.2008
HU08.11.2008
Former [2010/49]DK07.05.2008
EE07.05.2008
FI07.05.2008
IE07.05.2008
NL07.05.2008
RO07.05.2008
SI07.05.2008
SK07.05.2008
BG07.08.2008
SE07.08.2008
GR08.08.2008
ES18.08.2008
PT07.10.2008
Former [2009/23]DK07.05.2008
EE07.05.2008
FI07.05.2008
IE07.05.2008
NL07.05.2008
RO07.05.2008
SI07.05.2008
SK07.05.2008
BG07.08.2008
SE07.08.2008
ES18.08.2008
PT07.10.2008
Former [2009/22]DK07.05.2008
EE07.05.2008
FI07.05.2008
IE07.05.2008
NL07.05.2008
RO07.05.2008
SI07.05.2008
SK07.05.2008
SE07.08.2008
ES18.08.2008
PT07.10.2008
Former [2009/16]DK07.05.2008
FI07.05.2008
IE07.05.2008
NL07.05.2008
RO07.05.2008
SI07.05.2008
SK07.05.2008
SE07.08.2008
ES18.08.2008
PT07.10.2008
Former [2009/09]DK07.05.2008
FI07.05.2008
IE07.05.2008
NL07.05.2008
SI07.05.2008
SE07.08.2008
ES18.08.2008
PT07.10.2008
Former [2009/08]DK07.05.2008
FI07.05.2008
IE07.05.2008
NL07.05.2008
SI07.05.2008
SE07.08.2008
ES18.08.2008
Former [2009/07]FI07.05.2008
NL07.05.2008
SI07.05.2008
SE07.08.2008
ES18.08.2008
Former [2008/49]FI07.05.2008
NL07.05.2008
SI07.05.2008
ES18.08.2008
Former [2008/47]SI07.05.2008
ES18.08.2008
Former [2008/44]SI07.05.2008
Documents cited:Search[X]EP0876141  (BASF AG [DE]) [X] 1-7,9-11 * page 2, lines 42-49 * * page 3, lines 9-11 * * page 4, lines 39-42; claim 1 *;
 [X]  - VOIGT, R. ET AL., "Beiträge zur Erhöhung der Liberationsgeschwindigkeit von Propyphenazon aus peroralen festen Arzneiformen", DIE PHARMAZIE, (198501), vol. 40, no. 1, pages 39 - 44, XP001189632 [X] 1-7,9-11 * abstract * * page 40, column R, paragraph 5 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.